XML 19 R5.htm IDEA: XBRL DOCUMENT v3.25.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Notes Receivables from Stockholders
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income/(Loss)
Beginning balance (in shares) at Dec. 31, 2023 [1]   15,035,467        
Beginning balance at Dec. 31, 2023 $ 122,600 $ 2 [1] $ (10,111) $ 1,838,499 [1] $ (1,704,076) $ (1,714)
Increase (Decrease) in Stockholders' Equity            
Adjustment of transaction costs related to Business Combination (2,372)     (2,372) [1]    
Issuance of common stock for options exercised (in shares) [1]   4,254        
Issuance of common stock for options exercised 1,529     1,529 [1]    
Cancellation of common stock (in shares) [1]   (30,673)        
Stock-based compensation 23,120     23,120 [1]    
Tax withholding upon vesting of restricted stock units (1,736)     (1,736) [1]    
Shares issued for vested restricted stock units (in shares) [1]   127,254        
Shares issued for vested restricted stock units 0          
Vesting of common stock issued via notes receivable from stockholders (8)   (884) 876 [1]    
Settlement of notes receivable from stockholders     1,846 (1,846) [1]    
Net loss (147,067)       (147,067)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax 4,322         4,322
Ending balance (in shares) at Sep. 30, 2024 [1]   15,136,302        
Ending balance at Sep. 30, 2024 388 $ 2 [1] (9,149) 1,858,070 [1] (1,851,143) 2,608
Beginning balance (in shares) at Jun. 30, 2024 [2]   15,110,974        
Beginning balance at Jun. 30, 2024 44,908 $ 2 [2] (9,130) 1,852,417 [2] (1,796,933) (1,448)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock for options exercised (in shares) [2]   1,483        
Issuance of common stock for options exercised 74     74 [2]    
Stock-based compensation 5,924     5,924 [2]    
Tax withholding upon vesting of restricted stock units (364)     (364) [2]    
Shares issued for vested restricted stock units (in shares) [2]   23,845        
Vesting of common stock issued via notes receivable from stockholders 0   (19) 19 [2]    
Net loss (54,210)       (54,210)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax 4,056         4,056
Ending balance (in shares) at Sep. 30, 2024 [1]   15,136,302        
Ending balance at Sep. 30, 2024 $ 388 $ 2 [1] (9,149) 1,858,070 [1] (1,851,143) 2,608
Beginning balance (in shares) at Dec. 31, 2024 15,168,795 15,168,795        
Beginning balance at Dec. 31, 2024 $ (58,170) $ 2 (9,158) 1,863,288 (1,910,366) (1,936)
Increase (Decrease) in Stockholders' Equity            
Gain on troubled debt restructuring (see Note 10) 210,044     210,044    
Tax effect on gain on troubled debt restructuring (2,445)     (2,445)    
Issuance of common stock for options exercised (in shares)   203        
Issuance of common stock for options exercised 3     3    
Issuance of common stock under ATM program (in shares)   9,917        
Issuance of common stock under ATM program 589     589    
Stock-based compensation 13,596     13,596    
Tax withholding upon vesting of restricted stock units (in shares)   (110,658)        
Tax withholding upon vesting of restricted stock units (1,559)     (1,559)    
Shares issued for vested restricted stock units (in shares)   307,692        
Vesting of common stock issued via notes receivable from stockholders 3   (2) 5    
Net loss (125,952)       (125,952)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax $ 5,803         5,803
Ending balance (in shares) at Sep. 30, 2025 15,375,949 15,375,949        
Ending balance at Sep. 30, 2025 $ 41,912 $ 2 (9,160) 2,083,521 (2,036,318) 3,867
Beginning balance (in shares) at Jun. 30, 2025   15,274,145        
Beginning balance at Jun. 30, 2025 76,557 $ 2 (9,160) 2,077,303 (1,997,193) 5,605
Increase (Decrease) in Stockholders' Equity            
Tax effect on gain on troubled debt restructuring 2,276     2,276    
Issuance of common stock for options exercised (in shares)   203        
Issuance of common stock for options exercised 3     3    
Issuance of common stock under ATM program (in shares)   9,917        
Issuance of common stock under ATM program 589     589    
Stock-based compensation 4,536     4,536    
Tax withholding upon vesting of restricted stock units (in shares)   (47,095)        
Tax withholding upon vesting of restricted stock units (1,186)     (1,186)    
Shares issued for vested restricted stock units (in shares)   138,779        
Net loss (39,125)       (39,125)  
Other comprehensive income (loss) — foreign currency translation adjustment, net of tax $ (1,738)         (1,738)
Ending balance (in shares) at Sep. 30, 2025 15,375,949 15,375,949        
Ending balance at Sep. 30, 2025 $ 41,912 $ 2 $ (9,160) $ 2,083,521 $ (2,036,318) $ 3,867
[1] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.
[2] Periods have been adjusted to reflect the 1-for-50 reverse stock split on August 16, 2024. See Note 1 Organization and Nature of the Business - Reverse Stock Split, for additional information.